Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26FV7E5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,746
Award facts
- Contract value 100% obligated
- $9,745.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,745.98 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed-price contract with an ultimate completion date of January 21, 2026, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order is issued under AmerisourceBergen's existing $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Benlysta (belimumab) is a biologic treatment indicated for systemic lupus erythematosus, and its procurement through the DLA supply chain supports the Defense Health Agency's medical supply requirements for military personnel and beneficiaries. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a diverse portfolio of medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV7E5?
SPE2DR26FV7E5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FV7E5 worth?
The government has obligated $9,746 on SPE2DR26FV7E5.
Is contract SPE2DR26FV7E5 an order under another contract?
Yes. SPE2DR26FV7E5 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7E5 competed?
The extent of competition for SPE2DR26FV7E5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award